Concerns Surrounding Wacker Chemie's (ETR:WCH) Performance
Wacker Chemie AG's (ETR:WCH ) stock didn't jump after it announced some healthy earnings. We did some digging and believe investors may be worried about some underlying factors in the report.
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
An Unusual Tax Situation
We can see that Wacker Chemie received a tax benefit of €37m. This is meaningful because companies usually pay tax rather than receive tax benefits. We're sure the company was pleased with its tax benefit. However, the devil in the detail is that these kind of benefits only impact in the year they are booked, and are often one-off in nature. In the likely event the tax benefit is not repeated, we'd expect to see its statutory profit levels drop, at least in the absence of strong growth.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Wacker Chemie's Profit Performance
As we have already discussed Wacker Chemie reported that it received a tax benefit, rather than paying tax, in the last year. Given that sort of benefit is not recurring, a focus on the statutory profit might make the company seem better than it really is. Therefore, it seems possible to us that Wacker Chemie's true underlying earnings power is actually less than its statutory profit. But at least holders can take some solace from the 9.1% EPS growth in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. You'd be interested to know, that we found 1 warning sign for Wacker Chemie and you'll want to know about this.
Today we've zoomed in on a single data point to better understand the nature of Wacker Chemie's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Winter is coming! Here's a top stock to consider in an ISA for the rest of 2025
I'm looking for top UK shares that could rise in value over the remainder of the year and beyond. Here's one top momentum stock I think ISA investors like me should seriously consider. New gold price spurt? Gold prices have stepped back from April's record peaks above $3,500 per ounce. But the bullion market is beginning to bubble again as worries over global growth, rising inflation, and geopolitical challenges grow. The precious metal was last changing hands near $3,384 per ounce. And City analysts are starting to get excited again about where gold prices will reach in the coming quarters. Take the boffins at ING. On Thursday (7 August) they raised their forecasts for the next two years, predicting that 'potential US Fed rate cuts, along with continued central bank buying and ETF inflows, could send gold to fresh highs'. They now think gold will average $3,250 per ounce in 2025, up from a prior estimate of $3,128. And their projection of $3,512 for 2026 is up from $3,175 previously. Top mining stock I like the idea of buying gold stocks to seize this opportunity. It's why I've purchased the L&G Gold Mining ETF — an exchange-traded fund (ETF) containing a basket of 37 precious metals producers — for my own portfolio. This way, I stand a chance of making better returns than buying a gold price tracker or physical metal. When gold rises, profitability among mining stocks can boom, as their costs remain relatively fixed while revenues rise. A fund that holds many shares helps spread the risk that comes with mining companies. But, on the other hand, buying individual shares can generate even greater capital gains if they're operationally robust. This is the case with Serabi Gold (LSE:SRB) in 2025. The company — which owns exploration assets and working mines in Brazil — has risen 80.3% in value in the year to date. By comparison, my Legal & General gold miner's ETF is up 64.3%. The gold price has increased 28.9% over the period, in US dollar terms. Soaring production Serabi operates in the highly lucrative Tapajós region in Brazil, described as the world's third-largest alluvial gold field. The firm has ambitions to leverage this resource-rich area and is making a good fist of it — production is rising sharply thanks to ramp-ups at its Coringa mine, and was up 17% in the second quarter, at 10,532 ounces. It's on course to raise output to 44,000 to 47,000 ounces in 2025, and to reach: 60,000 ounces next year 70,000-75,000 ounces in 2027 100,000 ounces in 2028 With a string of promising exploration projects, too, Serabi could deliver solid long-term growth. A dirt-cheap gold share Today Serabi Gold trades at 200.7p per share. This means it carries a price-to-earnings (P/E) ratio of 3.9 times, a figure I don't think reflects its enormous growth potential. Given the bright outlook for gold prices and its impressive operational progress, ISA investors should give the company significant thought. The post Winter is coming! Here's a top stock to consider in an ISA for the rest of 2025 appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Royston Wild has positions in Legal & General Group Plc and Legal & General Ucits ETF Plc - L&g Gold Mining Ucits ETF. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025
Yahoo
an hour ago
- Yahoo
KeyBanc's Positive View on STERIS (STE) Driven by MedTech Momentum
STERIS plc (NYSE:STE) is one of the best defensive stocks to invest in according to analysts. As of August 1, the stock stands out as only the second name on this list with a positive year-to-date performance (+10.4%). The company generates more than $750 million in free cash flow annually, with guidance pointing to $770 million for FY 2026. This strong cash generation supports consistent shareholder returns through dividends and buybacks. Most recently, STERIS raised its quarterly dividend by 10% to $0.63 per share, pushing its dividend yield to approximately 1%. A cutting edge medical device in a sterile surgical setting, being operated by a skilled surgeon. In the long run, STERIS is targeting mid-to-high single-digit revenue growth and guides to delivering double-digit gains in adjusted earnings per share. This combination underpins the positive view around the stock. Analyst confidence in the name was further reflected on July 22, when KeyBanc analyst Brett Fishbin raised his price target on STERIS to $288 from $277 while reiterating an Overweight rating. According to KeyBanc, recent MedTech trends have been encouraging, especially in the hospital category, where procedure volumes grew at a high-single-digit rate through Q2. While tariff-related uncertainty remains a concern, KeyBanc believes these risks are now well understood and priced into consensus expectations. STERIS plc (NYSE:STE) provides innovative healthcare and life science products and services worldwide. Its offerings include consumable products, such as detergents and endoscopy accessories; services, including equipment installation and maintenance; and capital equipment, such as sterilizers and surgical tables. While we acknowledge the potential of STE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Most Oversold S&P 500 Stocks So Far in 2025 and 10 Most Oversold Semiconductor Stocks So Far in 2025. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
an hour ago
- Yahoo
BofA Stays Bullish on Coca-Cola (KO), Sees Upside Despite Volume Pressures
The Coca-Cola Company (NYSE:KO) is one of the best defensive stocks to invest in according to analysts. Coca-Cola has so far seen a robust performance, with YTD share price gains of around 11%, outperforming the broader S&P 500 Index by nearly 5%. With that, the stock is also among the only two stocks on our list of best defensive stocks that have posted positive share price performance (as of August 1), the second one being STERIS plc, covered at number 5. As the macroeconomic environment remains uncertain, quarterly results across corporations were under increased scrutiny, and Coca-Cola's results were no exception. The company reported its Q2 2025 results on July 22, which were overall steady. While the company maintained its organic revenue growth guidance of 5% to 6% for the full year, it narrowed its adjusted EPS outlook to around 3% tightening it from the earlier 2% to 3% range. Following the Q2 earnings report, an analyst from BofA maintained his Buy rating and raised the price target slightly from $77 to $78 on July 23. The update reflects better-than-expected Q2 2025 earnings per share, which surpassed the analyst's expectations. However, the analyst noted that despite the earnings beat, the stock underperformed on the day of the release, which he attributed mainly to the weaker-than-expected unit case volumes and broader market pressure. The analyst acknowledged these short-term challenges but pointed out that the volume comparisons will ease in the third quarter, which could help improve performance sequentially. Coca-Cola continues to show solid fundamentals, backed by over five decades of uninterrupted dividend growth and a well-established global brand. The Coca-Cola Company (NYSE:KO) is one of the world's largest beverage companies. Best known for its soft-drink, Coca-Cola, the company manufactures, markets, and distributes a wide range of beverages, including carbonated soft drinks, non-alcoholic beverage concentrates and syrups, as well as alcoholic beverages. While we acknowledge the potential of KO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Most Oversold S&P 500 Stocks So Far in 2025 and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data